Market Capitalization & Enterprise Value
Research-grade valuation history for MEDGF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.
Market Cap & Enterprise Value
Comparison of market capitalization and enterprise value over time
Market Cap
Enterprise Value
Market Cap History
Investor Valuation Insights
As of Dec 31, 2025EV/EBITDA
38.58x
Higher EV/EBITDA may imply premium pricing; growth durability should justify the multiple.
EV vs Market Cap Spread
229.31M
EV is +16.1% vs equity value
Capital Structure Signal
Net Debt Profile
Trend unavailable for selected history
Additional Multiples
EV/Sales: 10.61x
Net Debt/EBITDA: 2.45x
Share count trend unavailable
Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.
Market Cap & Enterprise Value Data
Free users can view the latest 3 records. Upgrade to see full history.
| Date | Market Cap | Enterprise Value | Stock Price | Shares |
|---|---|---|---|---|
| Dec 31, 2025 | 1.43B | 1.66B | $71.42 | 20.00M |
| Dec 31, 2024 | 1.61B | 1.82B | $81.03 | 19.92M |
| Dec 31, 2023 | 1.51B | 1.70B | $75.91 | 19.95M |
Dec 31, 2022 | — | — | — | — |
Dec 31, 2021 | — | — | — | — |
Dec 31, 2020 | — | — | — | — |
Dec 31, 2019 | — | — | — | — |
Dec 31, 2018 | — | — | — | — |
Dec 31, 2017 | — | — | — | — |
Dec 31, 2016 | — | — | — | — |
Dec 31, 2015 | — | — | — | — |